Technical Analysis for KPTI - Karyopharm Therapeutics Inc.

Grade Last Price % Change Price Change
grade F 5.44 -6.53% -0.38
KPTI closed down 6.53 percent on Friday, March 22, 2019, on approximately normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Up
See historical KPTI trend table...

Date Alert Name Type % Chg
Mar 22 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Mar 22 Weak + Overbought Other 0.00%
Mar 22 Wide Bands Range Expansion 0.00%
Mar 22 Overbought Stochastic Strength 0.00%
Mar 22 Upper Bollinger Band Touch Strength 0.00%
Mar 21 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -6.53%
Mar 21 New Uptrend Bullish -6.53%
Mar 21 Pocket Pivot Bullish Swing Setup -6.53%
Mar 21 Weak + Overbought Other -6.53%
Mar 21 Wide Bands Range Expansion -6.53%

Older signals for KPTI ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Karyopharm Therapeutics Inc., a clinical-stage pharmaceutical company, focuses on the discovery and development of drugs directed against nuclear transport targets for the treatment of cancer and other major diseases. The company's lead drug candidate includes Selinexor, an oral selective inhibitors of nuclear export (SINE) compound that specifically blocks XPO1 cargo binding is in Phase I clinical trials in patients with heavily pretreated relapsed and/or refractory hematological and solid tumor malignancies. Its other drug candidates comprise KPT-350 and related SINE compounds; PAK4 inhibitors; and Verdinexor, a SINE compound that is in Phase IIb clinical trials in pet dogs with newly-diagnosed or first relapse after chemotherapy lymphomas. The company was founded in 2008 and is based in Natick, Massachusetts.
Medicine Cancer Pharmaceutical Diseases Treatment Of Cancer Oncology Chemotherapy Occupational Safety And Health Antibody Drug Conjugates Pixantrone
Is KPTI a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 3 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 21.71
52 Week Low 3.92
Average Volume 1,934,311
200-Day Moving Average 13.0766
50-Day Moving Average 7.2574
20-Day Moving Average 4.672
10-Day Moving Average 4.943
Average True Range 0.5424
ADX 29.01
+DI 23.9842
-DI 21.2699
Chandelier Exit (Long, 3 ATRs ) 7.7728
Chandelier Exit (Short, 3 ATRs ) 5.5472
Upper Bollinger Band 5.712
Lower Bollinger Band 3.632
Percent B (%b) 0.87
BandWidth 44.520548
MACD Line -0.5263
MACD Signal Line -0.8313
MACD Histogram 0.3051
Fundamentals Value
Market Cap 256.43 Million
Num Shares 47.1 Million
EPS -2.69
Price-to-Earnings (P/E) Ratio -2.02
Price-to-Sales 2836.82
Price-to-Book 2.82
PEG Ratio -0.13
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 6.31
Resistance 3 (R3) 6.36 6.11 6.17
Resistance 2 (R2) 6.11 5.89 6.09 6.12
Resistance 1 (R1) 5.78 5.75 5.66 5.73 6.07
Pivot Point 5.53 5.53 5.47 5.51 5.53
Support 1 (S1) 5.20 5.31 5.08 5.15 4.81
Support 2 (S2) 4.95 5.17 4.93 4.76
Support 3 (S3) 4.62 4.95 4.72
Support 4 (S4) 4.57